Author:
Taverna Cecilia,Franchi Alessandro
Publisher
Springer International Publishing
Reference6 articles.
1. Dreux, N., Marty, M., Chibon, F., et al. (2010). Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: About a series of 1052 cases. Modern Pathology, 23(12), 1657–1666.
2. Fletcher C.D.M., Folpe A.L., & Hornick J.L. (2016). Mesenchymal tumours of the spermatic cord and testicular adnexa. In H. Moch, P.A. Humphrey, T.M. Ulbright, V.E. Reuter (Eds.) W.H.O. classification of tumours of the urinary system and male genital organs (4th edn, Vol. 8, pp. 253–256). Lyon: IARC
3. Hsieh, F., Chuang, K. T., Wu, Y. T., & Lin, C. H. (2018). Aggressive Angiomyxoma-report of a rare male buttock lesion. Plast Reconstr Surg Glob Open, 6(8), e1879.
4. Idrees, M. T., Hoch, B. L., Wang, B. Y., & Unger, P. D. (2006). Aggressive angiomyxoma of male genital region. Report of 4 cases with immunohistochemical evaluation including hormone receptor status. Annals of Diagnostic Pathology, 10(4), 197–204.
5. Steeper, T. A., & Rosai, J. (1983). Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. The American Journal of Surgical Pathology, 7(5), 463–475.